Jaclyn Kelley-Widmer says allowing migrants to work is an important part of alleviating the crisis. Stephen Yale-Loehr says that problems caused by the recent influx of migrants to New York can be resolved without the courts.
A Cornell historian says one of the most important aspects of Martin Luther King Jr.’s legacy was his insistence on speaking up against social and economic injustice.
Faculty in Cornell’s Action Research Collaborative (ARC) joined New York City and State policymakers and community members for ARC’s second symposium on June 22. The annual symposium is an opportunity for researchers, policymakers and community stakeholders to share their knowledge and advance equity in areas like nutrition and health, housing and social services, and youth development.
The Cornell Center for Materials Research (CCMR) is helping four small businesses advance their technology to grow the innovation economy in New York state.
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.
U.S. Secretary of Transportation Pete Buttigieg provided an intimate look at the most pressing issues in federal infrastructure planning during a conversation on November 2 with students and faculty members from the Cornell Jeb E. Brooks School of Public Policy and the Roosevelt House Public Policy Institute at Hunter College.
The 20 finalist startups battling for $3 million in prize money in the fifth annual Grow-NY Food and Agriculture Business Competition were selected from more than 320 applicants, including 81 entries from New York state.
Weill Cornell Medicine has received a three-year, nearly $6 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to lead one of three national contraceptive research centers.
Receiving a clot-busting drug in an ambulance-based mobile stroke unit increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, a new study shows.
In experiments of unprecedented scale, researchers at Weill Cornell Medicine and the NIH have advanced efforts to better understand and ultimately treat this common metabolic disease.